LUNGevity Foundation/Partnership for Cures Research Grant
Peter J. Mazzone, MD, MPH, FRCPC, FCCP
The Cleveland Clinic Foundation
Cleveland
Dr. Mazzone is identifying exhaled breath biomarkers for the detection of early-stage lung cancer. This breath biomarker work may also lead to a new way to characterize lung cancers, determine their prognosis, and predict and monitor their response to therapy.